权衡风险和回报:血液学家如何讨论异构造血细胞移植结果的不确定性?
Rachel A Rodenbach1, Thorunn Thordardottir1, Markus Brauer2
1University of Wisconsin Carbone Cancer Center, Madison, WI, USA.
Patient education and counseling
|February 11, 2024
概括
血液学家使用"摇摇欲"的语言来讨论异构造血细胞移植 (alloHCT) 的高风险,高回报性质. 这种沟通平衡了希望和担忧,帮助患者理解复杂的移植决策.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 医学沟通 医学沟通
背景情况:
- 全基性造血细胞移植 (alloHCT) 为血液癌症提供了潜在的治疗方法,但涉及到重大风险.
- 了解医生如何沟通这些复杂的风险和好处对于患者的决策至关重要.
研究的目的:
- 描述血液学家在讨论alloHCT的高风险,高回报概念时使用的沟通策略.
- 分析如何向患者介绍全源造血细胞移植的概念.
主要方法:
- 视频录制的虚拟患者接触的定性分析.
- 37名血液学家与演员互动,演出患有高风险骨髓质疏松综合征的患者.
主要成果:
- 血液学家经常采用"摇摇欲"的语言,动态地将所有HCT的风险和好处相对应.
- 沟通往往传达不确定性,在对话中在治疗潜力和治疗风险之间振荡.
- 最初,很少有血液学家就移植的风险和益处提出了明确的总体立场.
结论:
- 血液学家使用""的语言来传达与alloHCT相关的各种情绪和结果.
- "Teeter-totter"沟通可以有效地为患者教育和知情同意提供必要的风险-益处信息.
相关概念视频
Bone Marrow Sampling and Transplants
331
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
331
Tissue Transplantation
366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K


